^
Association details:
| Biomarker: | RAB5A expression |
|---|---|
| Cancer: | Breast Cancer |
| Drug: | Kadcyla (ado-trastuzumab emtansine) (Microtubule inhibitor, HER2-targeted antibody-drug conjugate) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
RAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancer
Published date:
11/05/2021
Excerpt:
RAB5A protein expression correlates with T-DM1 sensitivity in a subset of patients in the Kamilla study…
DOI:
https://doi.org/10.1038/s41467-021-26018-z
Trial ID:
